Search results
Results from the WOW.Com Content Network
The first BTO office director in 2014-2015 - Dr. Geoffrey Ling, MD. [4] The current BTO office director is Dr. Michael Koeris, who joined joined DARPA from Industry and is supported by Robert Saperstein, PhD. [5] Koeris’ predecessor was Dr. Kerri Dugan, who joined DARPA in 2019.
Geoffrey S. F. Ling is a medical doctor who retired from the United States Army as a colonel and was the CEO of On Demand Pharmaceuticals. He served as the founding director of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office from 2014 until 2016. [1]
DARPA comprises approximately 220 government employees in six technical offices, including nearly 100 program managers, who together oversee about 250 research and development programs. [8] The agency's current director, appointed in March 2021, is Stefanie Tompkins .
The Defense Advanced Research Projects Agency (DARPA, formerly ARPA) has been the military's in-house innovator since 1958, a year after the USSR launched Sputnik.DARPA is widely known for creating ARPAnet, the predecessor of the internet, and has been instrumental in advancing hardened electronics, brain-computer interface technology, drones, and stealth technology.
The Defense Sciences Office (DSO) is one of seven technical offices within DARPA, an agency of the U.S. Department of Defense that is responsible for the development of advanced technology for national security. [1] In a 2021 news story, DARPA described it "a highly exploratory office that identifies and accelerates new technologies." [2]
From 2016 to 2020, she served as a program manager in the Biological Technologies Office of DARPA, where she specialized in synthetic biology and biosecurity. Since 2018, she has been a senior advisor to the Nuclear Threat Initiative. [5] In 2020, she joined Ginkgo Bioworks as vice president of business development. [6]
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.
In 2007 Tompkins joined DARPA's Strategic Technology Office as a program manager. [7] In the next decade, according to DARPA, she held many roles at the agency, including a stint as director of the Defense Sciences Office. [1] In 2017 she took up the temporary position of acting deputy director of DARPA. [8]